Volume 25, Number 11—November 2019
Research Letter
Availability of Injectable Antimicrobial Drugs for Gonorrhea and Syphilis, United States, 2016
, Donald K. Cherry, Jami S. Leichliter, Laura H. Bachmann, Nicole A. Cummings, and Matthew Hogben
Table
On-site availability of drugs to manage gonorrhea and syphilis and likelihood of drug nonavailability by type and location of clinic, United States, 2016*
| Category | Weighted population, no. (95% CI) | On-site drug availability, % (95% CI) |
Likelihood of nonavailability† |
|||
|---|---|---|---|---|---|---|
| Yes | No | β | OR (95% CI) | |||
| Ceftriaxone, 250 mg, intramuscular | ||||||
| PCMH designation‡ | ||||||
| Yes | 44,028 (35,296–52,760) | 54.4 (42.1–66.3) | 45.6 (33.7–57.9) | Referent | Referent | |
| No | 89,381 (79,356–99,406) | 37.3 (30.0–45.0) | 62.7 (55.0–70.0) | 0.71 | 2.03 (1.15–3.57) | |
| Region of office§ | ||||||
| Northeast | 33,384 (28,666–38,102) | 34.3 (22.7–47.5) | 65.7 (52.5–77.3) | Referent | Referent | |
| South | 45,574 (39,694–51,454) | 49.0 (38.4–59.6) | 51.0 (40.4–61.6) | −0.63 | 0.53 (0.27–1.06) | |
| Midwest | 33,296 (28,374–38,218) | 41.4 (28.9–54.8) | 58.6 (45.2–71.1) | −0.28 | 0.76 (0.35–1.64) | |
| West |
37,228 (31,038–43,418) |
48.6 (35.8–61.6) |
51.4 (38.4–64.2) |
−0.62 |
0.54 (0.26–1.14) |
|
| Penicillin G benzathine, 2.5 million units, intramuscular | ||||||
| PCMH designation‡ | ||||||
| Yes | 44,028 (35,296–52,760 | 34.2 (23.2–46.6) | 65.8 (53.4–76.8) | Referent | Referent | |
| No | 89,381 (79,356–99,406) | 14.6 (9.5–21.1) | 85.4 (78.9–90.5) | 1.16 | 3.20 (1.63–6.29) | |
| Region of office§ | ||||||
| Northeast | 33,384 (28,666–38,102) | 17.8 (8.9–30.3) | 82.2 (69.7–91.1) | Referent | Referent | |
| South | 45,574 (39,694–51,454) | 32.1 (22.8–42.5) | 67.9 (57.5–77.2) | −0.83 | 0.43 (0.19–1.00) | |
| Midwest | 33,296 (28,374–38,218) | 15.5 (7.3–27.3) | 84.5 (72.7–92.7) | 0.22 | 1.25 (0.46–3.39) | |
| West | 37,228 (31,038–43,418) | 19.6 (9.4–33.8) | 80.4 (66.2–90.6) | −0.13 | 0.88 (0.32–2.40) | |
*The data source was the National Center for Health Statistics, National Ambulatory Medical Care Survey (5). All analyses were conducted by using SUDAAN (https://www.rti.org/impact/sudaan-statistical-software-analyzing-correlated-data) to account for the complex sampling design of the survey. OR, odds ratio; PCMH, patient-centered medical home.
†Likelihood determined by using a logistic regression model that included the factors PCMH designation and region of country. β is the coefficient of the variable, indicating direction and strength of the association.
‡PCMH designation of first-listed National Ambulatory Medical Care Survey–sampled office. An estimated weighted total of 149,483 office-based physicians indicated that they evaluate patients for or treat patients with sexually transmitted infections at their first-listed sampled office. PCMH data were missing (i.e., the physician refused to answer, did not know, or left blank or an instrument error occurred) for 10.8% of weighted office-based physicians treating gonorrhea and syphilis.
§Estimates might not sum to the estimated weighted total because of rounding of weighted numbers.
References
- Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017. Atlanta: US Department of Health and Human Services; 2018.
- Kirkcaldy RD, Bolan GA, Wasserheit JN. Cephalosporin-resistant gonorrhea in North America. JAMA. 2013;309:185–7. DOIPubMedGoogle Scholar
- Nurse-Findlay S, Taylor MM, Savage M, Mello MB, Saliyou S, Lavayen M, et al. Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: An evaluation from multi-country surveys and stakeholder interviews. PLoS Med. 2017;14:
e1002473 . DOIPubMedGoogle Scholar - Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(No. RR-3):1–137.PubMedGoogle Scholar
- Centers for Disease Control and Prevention National Center for Health Statistics. Ambulatory health care data. 2019 Jul 3 [cited 2019 May 29]. https://www.cdc.gov/nchs/ahcd/index.htm
- American Medical Association. Principles of the patient-centered medical home H-160.919. 2018 [cited 2019 May 29]. https://policysearch.ama-assn.org/policyfinder/detail/Principles%20of%20the%20Patient-Centered%20Medical%20Home%20H-160.919?uri=%2FAMADoc%2FHOD.xml-0-734.xml
- McHugh M, Shi Y, Ramsay PP, Harvey JB, Casalino LP, Shortell SM, et al. Patient-centered medical home adoption: results from aligning forces for quality. Health Aff (Millwood). 2016;35:141–9. DOIPubMedGoogle Scholar